SHL Telemedicine Appoints New CFO
Ticker: SHMLF · Form: 6-K · Filed: Feb 4, 2025 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | Feb 4, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, cfo
TL;DR
SHL Telemedicine gets a new CFO on March 1st, replacing the old one.
AI Summary
SHL Telemedicine Ltd. announced on February 4, 2025, the appointment of Lior Haalman as its new Chief Financial Officer, effective March 1, 2025. This follows the resignation of the current CFO, Amir Hai, whose departure is effective upon Haalman's start. The company is based in Tel Aviv, Israel.
Why It Matters
A change in a key executive position like CFO can impact investor confidence and the company's financial strategy and reporting.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a CFO change and does not contain significant financial or operational news.
Key Players & Entities
- SHL Telemedicine Ltd. (company) — The company making the announcement.
- Lior Haalman (person) — Appointed as the new Chief Financial Officer.
- Amir Hai (person) — Resigning Chief Financial Officer.
- February 4, 2025 (date) — Date of the press release and announcement.
- March 1, 2025 (date) — Effective date for the new CFO.
FAQ
Who has been appointed as the new Chief Financial Officer of SHL Telemedicine Ltd.?
Lior Haalman has been appointed as the new Chief Financial Officer.
When is the new CFO's appointment effective?
The appointment of Lior Haalman is effective March 1, 2025.
Who is the current Chief Financial Officer that is resigning?
Amir Hai is the current Chief Financial Officer who announced his resignation.
What is the effective date of the current CFO's resignation?
The current CFO's resignation will be effective upon the new CFO's start date.
What type of filing is this report?
This report is a Form 6-K, a Report of Foreign Private Issuer.
Filing Stats: 252 words · 1 min read · ~1 pages · Grade level 10.5 · Accepted 2025-02-04 06:02:30
Filing Documents
- zk2532649.htm (6-K) — 9KB
- exhibit_99-1.htm (EX-99.1) — 7KB
- image0.jpg (GRAPHIC) — 437KB
- image1.jpg (GRAPHIC) — 266KB
- 0001178913-25-000305.txt ( ) — 985KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-41641 SHL TELEMEDICINE LTD. (Translation of registrant's name into English) 90 Yigal Alon Street Tel Aviv 67891, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXPLANATORY NOTE On February 4, 2025, SHL Telemedicine Ltd. (the " Company ") issued a press release, a copy of which is furnished herewith as Exhibit 99.1. In the press release, the Company announced that it has appointed Lior Haalman to serve as the Company's new Chief Financial Officer, effective March 1, 2025. Amir Hai, the Company's current Chief Financial Officer, announced his resignation, which will be effective upon Mr. Haalman assuming the position of Chief Financial Officer. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546) . Exhibit Description 99.1 Press release, dated February 4, 2025, issued by the Company. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL Telemedicine Ltd. By: /s/ Amir Hai Amir Hai Chief Financial Officer February 4, 2025